• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性细胞间黏附分子-25(sCD25)及细胞毒性T淋巴细胞(CTL)脱颗粒试验用于筛查原发性噬血细胞性淋巴组织细胞增生症患者的效能:一项中国的大规模多中心研究

The performance of sCD25 and CTLs degranulation test for screening patients with primary hemophagocytic lymphohistiocytosis: a large-scale multicenter study in China.

作者信息

Zheng Wenshuai, Chen Zhaoguang, Cai Yibo, Wu Zongze, Du Zhenlan, Li Xiaohong, Li Beicheng, Zhu Shibin, Ning Hongmei

机构信息

Department of Hematology, Hainan Hospital of Chinese People's Liberation Army (PLA) General Hospital, Sanya, Hainan, China.

Hematology and Oncology Department of Pediatrics, The Seventh Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

出版信息

Front Immunol. 2025 Jul 2;16:1616541. doi: 10.3389/fimmu.2025.1616541. eCollection 2025.

DOI:10.3389/fimmu.2025.1616541
PMID:40672957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12263684/
Abstract

BACKGROUND

Hemophagocytic lymphohistiocytosis can be classified as primary HLH (pHLH) and secondary HLH. The early identify of pHLH can facilitate successful treatment. The rapid screening test greatly facilitated the diagnostic process of pHLH. However, there are rare studies to explore the ability of sCD25 and cytotoxic T lymphocytes (CTLs) degranulation test to rapidly screen pHLH.

METHODS

We validated the accuracies of sCD25 and CTLs degranulation test in screening pHLH in 1224 clinically confirmed or suspected HLH patients through calculating area under the curve (AUC) and diagnostic parameters at optimal threshold.

RESULTS

The sensitivities of sCD25 to identify pHLH with defects in cytotoxic pathway genes was 75.9%, with specificities of 57.3% and AUC of 0.640. The sensitivities of CTLs degranulation test to identify pHLH with defects in degranulation pathway genes was 87.0%, with specificities of 69.0% and AUC of 0.794. The sensitivities of combination of sCD25 and CTLs degranulation test to identify pHLH with defects in cytotoxic pathway genes was 90.0%, with specificities of 69.8% and AUC of 0.833.

CONCLUSION

For identifying pHLH, CTLs degranulation test is more sensitive and no less specific than sCD25 and the combination of sCD25 and CTLs degranulation test can improve the accuracy further.

摘要

背景

噬血细胞性淋巴组织细胞增生症可分为原发性HLH(pHLH)和继发性HLH。pHLH的早期识别有助于成功治疗。快速筛查试验极大地促进了pHLH的诊断过程。然而,鲜有研究探讨可溶性CD25(sCD25)和细胞毒性T淋巴细胞(CTL)脱颗粒试验快速筛查pHLH的能力。

方法

我们通过计算曲线下面积(AUC)和最佳阈值下的诊断参数,验证了sCD25和CTL脱颗粒试验在1224例临床确诊或疑似HLH患者中筛查pHLH的准确性。

结果

sCD25识别细胞毒性通路基因缺陷型pHLH的敏感性为75.9%,特异性为57.3%,AUC为0.640。CTL脱颗粒试验识别脱颗粒通路基因缺陷型pHLH的敏感性为87.0%,特异性为69.0%,AUC为0.794。sCD25与CTL脱颗粒试验联合识别细胞毒性通路基因缺陷型pHLH的敏感性为90.0%,特异性为69.8%,AUC为0.833。

结论

对于识别pHLH,CTL脱颗粒试验比sCD25更敏感且特异性不低,sCD25与CTL脱颗粒试验联合可进一步提高准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e1/12263684/4c971a6f2e28/fimmu-16-1616541-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e1/12263684/7eb55b98fe7a/fimmu-16-1616541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e1/12263684/c15f49946211/fimmu-16-1616541-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e1/12263684/4c971a6f2e28/fimmu-16-1616541-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e1/12263684/7eb55b98fe7a/fimmu-16-1616541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e1/12263684/c15f49946211/fimmu-16-1616541-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e1/12263684/4c971a6f2e28/fimmu-16-1616541-g003.jpg

相似文献

1
The performance of sCD25 and CTLs degranulation test for screening patients with primary hemophagocytic lymphohistiocytosis: a large-scale multicenter study in China.可溶性细胞间黏附分子-25(sCD25)及细胞毒性T淋巴细胞(CTL)脱颗粒试验用于筛查原发性噬血细胞性淋巴组织细胞增生症患者的效能:一项中国的大规模多中心研究
Front Immunol. 2025 Jul 2;16:1616541. doi: 10.3389/fimmu.2025.1616541. eCollection 2025.
2
Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.血清 sCD25/铁蛋白比值联合 MCP-1 是鉴别以 HLH 为首发表现的 LAHS 的有效预测指标。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8521-8533. doi: 10.1007/s00432-023-04781-4. Epub 2023 Apr 24.
3
Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people.老年人即将发生和当前失水脱水的识别的临床症状、体征及检查
Cochrane Database Syst Rev. 2015 Apr 30;2015(4):CD009647. doi: 10.1002/14651858.CD009647.pub2.
4
Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.用于识别结直肠癌患者营养不良的营养评估工具的诊断测试准确性:一项系统综述
JBI Database System Rev Implement Rep. 2015 May 15;13(4):141-87. doi: 10.11124/jbisrir-2015-1673.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.评估免疫化学疗法和干细胞移植对儿童 EBV 相关噬血细胞性淋巴组织细胞增生症的作用:系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2012 May;16(5):672-8.
7
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
8
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
9
Hyperferritinemia Screening to Aid Identification and Differentiation of Patients with Hyperinflammatory Disorders.高血铁蛋白血症筛查有助于识别和区分高炎症性疾病患者。
J Clin Immunol. 2024 Sep 12;45(1):4. doi: 10.1007/s10875-024-01797-4.
10
Clinicopathological and Immunogenetic Characterization in 8 Patients with Familial Hemophagocytic Lymphohistiocytosis Type 2: A Study from North India with Literature Review.8例2型家族性噬血细胞性淋巴组织细胞增生症患者的临床病理及免疫遗传学特征:来自印度北部的一项研究及文献综述
J Clin Immunol. 2025 Jun 19;45(1):108. doi: 10.1007/s10875-025-01895-x.

本文引用的文献

1
Hemophagocytic Lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症
Arch Pathol Lab Med. 2022 Apr 1;146(4):507-519. doi: 10.5858/arpa.2020-0802-RA.
2
Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders.1892 例疑诊遗传性 HLH 疾病患者的致病变异的频率和谱。
Blood Adv. 2020 Jun 23;4(12):2578-2594. doi: 10.1182/bloodadvances.2020001605.
3
A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study.成人继发性噬血细胞性淋巴组织细胞增生症患者的综合分析:一项前瞻性队列研究。
Ann Hematol. 2020 Sep;99(9):2095-2104. doi: 10.1007/s00277-020-04083-6. Epub 2020 May 21.
4
Genotype characteristics and immunological indicator evaluation of 311 hemophagocytic lymphohistiocytosis cases in China.中国 311 例噬血细胞性淋巴组织细胞增生症的基因型特征及免疫指标评价。
Orphanet J Rare Dis. 2020 May 6;15(1):112. doi: 10.1186/s13023-020-01390-z.
5
Genetic variant spectrum in 265 Chinese patients with hemophagocytic lymphohistiocytosis: Molecular analyses of PRF1, UNC13D, STX11, STXBP2, SH2D1A, and XIAP.265 例噬血细胞性淋巴组织细胞增生症患者的遗传变异谱:PRF1、UNC13D、STX11、STXBP2、SH2D1A 和 XIAP 的分子分析。
Clin Genet. 2018 Aug;94(2):200-212. doi: 10.1111/cge.13363. Epub 2018 May 11.
6
Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH.可溶性白细胞介素-2受体是成人噬血细胞性淋巴组织细胞增生症的一项敏感诊断检测。
Blood Adv. 2017 Dec 6;1(26):2529-2534. doi: 10.1182/bloodadvances.2017012310. eCollection 2017 Dec 12.
7
Hemophagocytic Lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症。
Annu Rev Pathol. 2018 Jan 24;13:27-49. doi: 10.1146/annurev-pathol-020117-043625. Epub 2017 Sep 13.
8
Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.可溶性白细胞介素-2受体在噬血细胞综合征中的临床应用:一项系统综述。
Ann Hematol. 2017 Aug;96(8):1241-1251. doi: 10.1007/s00277-017-2993-y. Epub 2017 May 12.
9
Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH.对于筛查遗传性噬血细胞性淋巴组织细胞增生症(HLH)患者,穿孔素和CD107a检测优于自然杀伤(NK)细胞功能检测。
Blood. 2017 Jun 1;129(22):2993-2999. doi: 10.1182/blood-2016-12-753830. Epub 2017 Mar 7.
10
A CD57 CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients.CD57细胞毒性T淋巴细胞脱颗粒试验可有效识别3型家族性噬血细胞性淋巴组织细胞增生症患者。
J Clin Immunol. 2017 Jan;37(1):92-99. doi: 10.1007/s10875-016-0357-3. Epub 2016 Nov 28.